ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

ACHL Achilles Therapeutics PLC

1.27
0.08 (6.72%)
Mar 28 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 282,880
Bid Price 1.20
Ask Price 1.29
News -
Share Name Share Symbol Market Stock Type
Achilles Therapeutics PLC ACHL NASDAQ Depository Receipt
  Price Change Price Change % Share Price Last Trade
0.08 6.72% 1.27 19:00:00
Open Price Low Price High Price Close Price Previous Close
1.22 1.19 1.29 1.25 1.19
Trades Shares Traded VWAP Financial Volume Average Volume
600 282,880  1.25  352,396 -
Last Trade Type Quantity Price Currency
18:39:16 formt 1,000  1.27 USD

Achilles Therapeutics PLC Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
0 0.00 - 7.32M -71.18M - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

News Achilles Therapeutics

Date Time Source Heading
2/05/202406:00GlobeNewswire Inc.Achilles Therapeutics to Present at the 10th Annual..
2/01/202412:14Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
12/18/202306:00GlobeNewswire Inc.Achilles Therapeutics Announces Publication of Nature Cancer..
11/13/202315:36Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/13/202315:30GlobeNewswire Inc.Achilles Therapeutics Reports Third Quarter 2023 Financial..
11/01/202316:26Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
9/22/202315:42Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
9/22/202315:30GlobeNewswire Inc.Achilles Therapeutics Receives Nasdaq Deficiency Notice..
9/20/202307:45InvestorsHub NewsWirePathways to Progress: How Orphan Drug Designation Sparks..
8/17/202314:16Edgar (US Regulatory)Form 144 - Report of proposed sale of securities
8/04/202306:42Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
8/04/202306:00GlobeNewswire Inc.Achilles Therapeutics Reports Second Quarter 2023 Financial..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No ACHL Message Board. Create One! See More Posts on ACHL Message Board See More Message Board Posts

ACHL Historical

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.00%
1 Month0.000.000.000.0000.000.00%
3 Months0.000.000.000.0000.000.00%
6 Months0.000.000.000.0000.000.00%
1 Year0.000.000.000.0000.000.00%
3 Years0.000.000.000.0000.000.00%
5 Years0.000.000.000.0000.000.00%

Achilles Therapeutics PLC is a biopharmaceutical company. It is developing novel cancer immunotherapies targeting clonal neoantigens. The company has two ongoing trials, the CHIRON trial in patients with advanced non-small-cell lung cancer and the THETIS trial in patients with recurrent or metastatic melanoma.

Your Recent History

Delayed Upgrade Clock